Published :
Tables : 52
Figures : 47
Category : Healthcare
No. of Pages : 233
Report Code : HC-1270
Transplant Diagnostics Market is poised to value USD 6775.59 million by 2028 end at a CAGR of 7.2% during the forecast period 2022 to 2028. Rising number of stem-cell-based, soft tissues, and solid transplantation, increasing geriatric population, rising occurrence of persistent diseases, augmentation in laboratory automation of diagnostic operations that are assisted by robots and advancements in technology advancement in human leukocyte antigen typing are some of the crucial factors driving the growth of the global transplant diagnostics market. Additionally, an increase in public and private investments to develop novel human leukocyte antigen (HLA) products for testing, soaring number of HLA applications in diagnostics, improvement in healthcare infrastructure, especially in developing nations, consistent reduction average gene sequencing costs and rising bases of installation of NGS and PCR instruments are steering the global transplant diagnostic market growth. Although, factors like high NGS and PCR instrument costs, finite medical rendering for transplantation operations and a massive difference between annual transplantation and organ donation are the important factors responsible for impeding market growth. Increasing penetration of the market in emerging economies in order to develop products of transplant diagnostics and rising priority shift from using serological assay method to HLA profiling based on genomes would open further opportunities for the growth of the transplant diagnostic market. New product developments and product announcements are amongst the primary global market trends. North America subjugates the global market owing to consistent gene sequencing average cost reduction, public and funding for HLA development and increasing number of solid organ and stem cell-based transplantation in the region. The Asia Pacific region is predicted to showcase a high growth rate in the next decade in the global market with India and China being the fastest escalating markets in the region. The important steering forces for the market in developing economies are large patient pools, improvements in healthcare infrastructure, increasing private and public support in order to develop HLA technologies, and growing emphasis of life science organizations in the region. Key players included in the global transplant diagnostics industry are Becton, Dickinson and Co., Biofortuna, Biomerieux SA, Bio-Rad Laboratories, Caredx, F.Hoffman-La Roche Ltd., Gendx, Hologic, illumine, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific. Transplant Diagnostics Market Segmentation: By Product and Services Reagents Instruments Software and Services By Technology • Molecular Assays o PCR-Based Molecular Assay • Real-Time PCR • Sequence-Specifier Primer-PCR • Sequence-Specific Oligonucleotide-PCR • Others PCR-Based Molecular Assays o Sequence-Based Molecular Assays • Sanger Sequencing • Next-Generation Sequencing • Others Sequencing Molecular Assays • Non-Molecular Assays By Transplant Type • Solid Organ Transplant o Kidney Transplant o Liver Transplant o Heart Transplant o Lung Transplant o Pancreas Transplant o Other Organ Transplantations • Stem Cell Transplant • Soft Tissue Transplant • Bone Marrow Transplantation By Application • Diagnostic Application o Pre-Transplantation Diagnostics • Infectious Disease Testing • Histocompatibility Testing • Blood Profiling o Post-Transplantation Diagnostics • Research Applications By End User Independent Reference Laboratories Hospitals & Transplant Centres Research Laboratories & Academic Institutes By Region North America Europe Asia Pacific Latin America Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global market by product and services, by technology, by transplant type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising number of stem-cell-based, soft tissues, and solid transplantation, increasing geriatric population, rising occurrence of persistent diseases, augmentation in laboratory automation of diagnostic operations that are assisted by robots and advancements in technology advancement in human leukocyte antigen typing are some of the crucial factors driving the growth of the global transplant diagnostics market. Additionally, an increase in public and private investments to develop novel human leukocyte antigen (HLA) products for testing, soaring number of HLA applications in diagnostics, improvement in healthcare infrastructure, especially in developing nations, consistent reduction average gene sequencing costs and rising bases of installation of NGS and PCR instruments are steering the global transplant diagnostic market growth.
Although, factors like high NGS and PCR instrument costs, finite medical rendering for transplantation operations and a massive difference between annual transplantation and organ donation are the important factors responsible for impeding market growth.
Increasing penetration of the market in emerging economies in order to develop products of transplant diagnostics and rising priority shift from using serological assay method to HLA profiling based on genomes would open further opportunities for the growth of the transplant diagnostic market. New product developments and product announcements are amongst the primary global market trends.
North America subjugates the global market owing to consistent gene sequencing average cost reduction, public and funding for HLA development and increasing number of solid organ and stem cell-based transplantation in the region. The Asia Pacific region is predicted to showcase a high growth rate in the next decade in the global market with India and China being the fastest escalating markets in the region. The important steering forces for the market in developing economies are large patient pools, improvements in healthcare infrastructure, increasing private and public support in order to develop HLA technologies, and growing emphasis of life science organizations in the region.
Key players included in the global transplant diagnostics industry are Becton, Dickinson and Co., Biofortuna, Biomerieux SA, Bio-Rad Laboratories, Caredx, F.Hoffman-La Roche Ltd., Gendx, Hologic, illumine, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific.
Transplant Diagnostics Market Segmentation:
By Product and Services
By Technology
• Molecular Assays o PCR-Based Molecular Assay • Real-Time PCR • Sequence-Specifier Primer-PCR • Sequence-Specific Oligonucleotide-PCR • Others PCR-Based Molecular Assays o Sequence-Based Molecular Assays • Sanger Sequencing • Next-Generation Sequencing • Others Sequencing Molecular Assays • Non-Molecular Assays
By Transplant Type
• Solid Organ Transplant o Kidney Transplant o Liver Transplant o Heart Transplant o Lung Transplant o Pancreas Transplant o Other Organ Transplantations • Stem Cell Transplant • Soft Tissue Transplant • Bone Marrow Transplantation
By Application
• Diagnostic Application o Pre-Transplantation Diagnostics • Infectious Disease Testing • Histocompatibility Testing • Blood Profiling o Post-Transplantation Diagnostics • Research Applications
By End User
By Region
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.2.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Transplant Diagnostics MarketVariables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biotech Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Molecular Assay Technology 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Transplant Diagnostics MarketAnalysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Transplant Diagnostics Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Reagents 7.2. Instruments 7.3. Software and Services 8. Global Transplant Diagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Molecular Assay 8.1.1. PCR-Based Molecular Assay 8.1.1.1. Real-Time PCR 8.1.1.2. Sequence-Specifier Primer PCR 8.1.1.3. Sequence-Specific Oligonucleotide-PCR 8.1.1.4. Other PCR-Based Molecular Assay 8.1.2. Sequence Based Molecular Assays 8.1.2.1. Sanger Sequencing 8.1.2.2. Next-Generation Sequencing 8.1.2.3. Other Sequencing-Based Molecular Assays 8.2. Non-Molecular Assay 9. Transplant Diagnostics Market, By Transplant Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Solid Organ Transplantation 9.1.1. Kidney Transplantation 9.1.2. Liver Transplantation 9.1.3. Heart Transplantation 9.1.4. Lung Transplantation 9.1.5. Pancreas Transplantation 9.1.6. Other Organ Transplantations 9.2. Stem-Cell Transplantation 9.3. Soft-Tissue Transplantation 9.4. Bone Marrow Transplantation 10. Global Transplant Diagnostics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Diagnostics 10.1.1. Pre-Transplantation Diagnostics 10.1.1.1. Infectious Disease Testing 10.1.1.2. Histocompatibility Testing 10.1.1.3. Blood Profiling 10.1.2. Post-Trnaplantatio0n Diagnostics 10.2. Research Applications 11. Global Transplant Diagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Independent Reference Laboratories 11.2. Hospitals and Transplant Centers 11.3. Research Laboratories and Academic Institutions 12. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 18.1 BECTON, DICKINSON AND CO. 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2 BIOFORTUNA 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3 BIOMERIEUX SA 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4 BIO-RAD LABORATORIES 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5 CAREDX 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6 GENDX 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7 F-HOFFMANN LA ROCHE AG 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8 HOLOGIC INC. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9 ILLUMINE 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10 IMMUCOR 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11 LUMINEX 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12 MERCK KGAA 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13 OMIXON 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14 QIAGEN 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15 THERMO FISHER SCIENTIFIC 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics